- Home
- SPRY vs EVV Comparison
SPRY vs EVV Comparison
Compare SPRY & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- EVV
- Stock Information
- Founded
- SPRY 2015
- EVV 2003
- Country
- SPRY United States
- EVV United States
- Employees
- SPRY N/A
- EVV N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- EVV Finance/Investors Services
- Sector
- SPRY Health Care
- EVV Finance
- Exchange
- SPRY Nasdaq
- EVV Nasdaq
- Market Cap
- SPRY 1.1B
- EVV 1.2B
- IPO Year
- SPRY N/A
- EVV N/A
- Fundamental
- Price
- SPRY $9.59
- EVV $10.11
- Analyst Decision
- SPRY Strong Buy
- EVV
- Analyst Count
- SPRY 4
- EVV 0
- Target Price
- SPRY $31.25
- EVV N/A
- AVG Volume (30 Days)
- SPRY 2.5M
- EVV 323.7K
- Earning Date
- SPRY 11-10-2025
- EVV 01-01-0001
- Dividend Yield
- SPRY N/A
- EVV 9.66%
- EPS Growth
- SPRY N/A
- EVV N/A
- EPS
- SPRY N/A
- EVV N/A
- Revenue
- SPRY $142,772,000.00
- EVV N/A
- Revenue This Year
- SPRY N/A
- EVV N/A
- Revenue Next Year
- SPRY $193.13
- EVV N/A
- P/E Ratio
- SPRY N/A
- EVV N/A
- Revenue Growth
- SPRY 5459.66
- EVV N/A
- 52 Week Low
- SPRY $6.66
- EVV $8.52
- 52 Week High
- SPRY $18.90
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- SPRY 57.78
- EVV 56.75
- Support Level
- SPRY $6.66
- EVV $9.85
- Resistance Level
- SPRY $7.40
- EVV $9.99
- Average True Range (ATR)
- SPRY 0.80
- EVV 0.07
- MACD
- SPRY 0.21
- EVV 0.01
- Stochastic Oscillator
- SPRY 78.83
- EVV 87.93
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.